Ingevity Q2 2025 Earnings Call Transcript

Quartr
Provided by Quartr
August 5, 2025

Key Takeaways

  • Positive Sentiment: Ingevity delivered a consolidated 30.1% EBITDA margin in Q2 and generated strong free cash flow, reducing net leverage to 3× and targeting below 2.8× by year-end.
  • Negative Sentiment: The APT segment recorded a noncash $184 million goodwill impairment due to tariff uncertainty and weak industrial markets, with Q2 sales down 10% and EBITDA of just $1 million.
  • Positive Sentiment: Performance Chemicals (Roadtec) achieved near-20% EBITDA margin—the highest in almost two years—after consuming high-cost CTO inventory and now expects full-year margin in the high single to low double digits.
  • Neutral Sentiment: Second-quarter sales fell 7% to $365 million driven by portfolio repositioning, wet weather and indirect tariff impacts, but adjusted gross margin rose 600 bps, lifting adjusted EBITDA by 9%.
  • Positive Sentiment: The sale processes for the Industrial Specialties business and CTO Refinery are in advanced stages, and an investor update on the strategic portfolio review is expected later this year or early next year.
AI Generated. May Contain Errors.
Earnings Conference Call
Ingevity Q2 2025
00:00 / 00:00

Transcript Sections

Skip to Participants
Operator

My name is Adam, and I'll be your operator today.

Operator

I'll now hand the floor to John Leiparber to begin. Sir, John, please go ahead when you're ready.

John Nypaver
John Nypaver
Vice President of Treasurer & Investor Relations at Ingevity

Thank you, Adam. Good morning, and welcome to Ingevity's second quarter twenty twenty five earnings call. Earlier this morning, we posted a presentation on our investor site that you can use to follow today's discussion.

John Nypaver
John Nypaver
Vice President of Treasurer & Investor Relations at Ingevity

It can be found on ir.ingevity.com under Events and Presentations. Also throughout this call, we may refer to non GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP measures. Definitions of these non GAAP financial measures and reconciliations to comparable GAAP measures are included in our earnings release and are also in our most recent Form 10 ks. We may also make forward looking statements regarding future events and future financial performance of the company during this call, and we caution you that these statements are just projections, and actual results or events may differ materially from those projections as further described in our earnings release. Our agenda is on Slide three.

John Nypaver
John Nypaver
Vice President of Treasurer & Investor Relations at Ingevity

Our speakers today are David Lee, our CEO and Mary Dean Hall, our CFO. Dave will provide introductory comments. Mary will follow with a review of our consolidated financial performance and the business segment results for the quarter. Dave will then provide closing comments and discuss 2025 guidance. With that, over to you, Dave.

David Li
David Li
President, CEO & Director at Ingevity

Thanks, John, and good morning, everyone. This week marks my fourth month with Ingevity. As I've traveled to our sites and met with our teams globally, I've been energized by the passion and pride our people bring to work every day. The Ingeva Way, our shared values and mission to purify, protect and enhance the world around us is deeply embedded across the company. And what I consistently hear from our organization is that they feel we have reached an inflection point and are ready to start winning again.

David Li
David Li
President, CEO & Director at Ingevity

This quarter was another clear demonstration of our strong execution, ability to deliver results and disciplined focus on profitability, which drove significant free cash flow and leverage improvement. Our leverage has improved to three times, which reflects a full turn improvement in less than a year. Our strong profitability was driven by Performance Materials, which delivered another quarter of EBITDA margins above 50% and our successful reposition actions in Performance Chemicals, resulting in a consolidated EBITDA margin of 30%. Also, we are making meaningful progress on our strategic portfolio assessment. The sale process for our Industrial Specialties business and CTO Refinery has reached an advanced stage, and we expect to share an update soon.

David Li
David Li
President, CEO & Director at Ingevity

We are also advancing our review of the entire portfolio with a focus on strategic fit and value creation. I'll share more about where we're heading in my closing comments. For now, I'll hand it over to Mary to walk through the quarter in more detail.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Thanks, Dave, and good morning all. Please turn to Slide five. Second quarter sales of $365,000,000 were down 7% versus Q2 last year due primarily to repositioning actions in Industrial Specialties, combined with wet weather and impacting paving activity in Roadtec and indirect tariff impacts on the APT volumes, particularly in Europe. Despite the sales decline, adjusted gross margin improved 600 basis points, driving a 9% increase in adjusted gross profit. Most of this improvement flowed through to adjusted earnings and adjusted EBITDA with adjusted earnings up 39% and adjusted EBITDA up 9%.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Our adjusted EBITDA margin improved over 400 basis points to 30.1%, even as spend increased to support investments in innovation and performance materials to drive future growth and in equipment for APT to improve operational efficiency and cost control. During the quarter, we recorded a noncash goodwill impairment charge of $184,000,000 for our APT segment. Shifts in this segment's customer order patterns due to tariff uncertainty and ongoing weakness in global industrial markets led us to conduct an interim goodwill impairment test. Updated forecasts and market assumptions, including a higher discount rate, resulted in the conclusion that APT's goodwill was fully impaired. My comments going forward exclude the impact of this charge, and a full reconciliation to GAAP results is provided in the appendix.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Please turn to Slide six for financial highlights of our consolidated results. The consistent EBITDA growth we've delivered combined with improved free cash flow has allowed us to accelerate our reduction in net leverage. The chart in the upper left of the slide shows how quickly we are driving that leverage toward our goal of two to 2.5 times. Also note the CapEx chart in the right top right of the slide. While CapEx spending year to date appears light, this reflects our normal spend pattern, and we continue to expect CapEx to be in the 50,000,000 to $70,000,000 range for the full year.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

I'll point out that our work to optimize our manufacturing footprint has structurally lowered our maintenance CapEx requirements, and our guide for this year reflects those benefits. As a result of improved adjusted earnings, disciplined working capital management and lower CapEx, we are raising the midpoint of our free cash flow guide and we are confident we will be below 2.8 times by year end. Turning to Slide seven. Performance Materials sales declined about $3,000,000 or 2% as higher revenue in North America was offset by declines in Europe and Asia, excluding China where sales were flat year over year. Europe's decline was attributed to tariff related uncertainty and the decline in Asia ex China was due to timing of customer orders, which benefited Q2 last year.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Auto production forecasts are being revised frequently as the tariff landscape continues to shift and have improved since April, particularly for North America. However, expectations still call for lower auto production year over year in all major markets except China. We have reflected the most recent information we have in our updated guidance. EBITDA margin ended the quarter just over 50%. The decline in margin year over year was due to the slightly lower revenue I mentioned, investments we made in innovation to drive future growth and certain onetime employee compensation costs.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

We continue to expect full year segment EBITDA margin to be above 50%. Please turn to Slide eight for APP results. Weaker customer demand, partly attributed to tariff uncertainty and price concessions to address competitive pressures, contributed to a 10% drop in sales in our APT segment. Last quarter, we commented that direct impacts from tariffs were expected to be minimal for our segments, and that continues to hold true. However, during the quarter, we began to see customer demand weaken further in our APT segment due to indirect tariff impacts.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

As we've noted before, APT is our most globally diversified business and the indirect impact of tariffs has been meaningful to APT's results. We have seen this most clearly in footwear and apparel and automotive markets, particularly in Europe, where our customers slowed their order patterns as a result of tariff uncertainty and concern over increased costs. We expect this uncertainty to continue and to impact customer demand in the second half of the year. In addition, our APT plant in The U. K.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Was down for an extended period of time to install new boilers as we discussed last quarter. The outage cost of about $5,500,000 in combination with the top line pressures I just discussed resulted in EBITDA of about $1,000,000 for the quarter. I'm happy to report that the boilers are up and running and are expected to give us better control over energy costs and improve operational efficiency going forward. Also, as markets and businesses adjust to the new tariff environment, our team is moving aggressively to reorganize and refocus our commercial efforts to align with our customers as they pivot between regions and markets. Due to the shifting landscape and current market conditions, we expect full year revenue in APP to be down mid to high single digits as a result of lower industrial demand with EBITDA margin between 1520%.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Please turn to Slide nine for Performance Chemicals results. Sales were down about 10% as last year's results included the final remnants of revenue generated from the lower margin markets we exited as a result of repositioning actions. Lower sales in Roadtec also contributed to the drop in sales as we saw a slow start to the paving season due to wet weather. And that may sound like a repeat of last year, which was also affected by wet weather, but last year was more concentrated in terms of geography. This year, wider swath of the country was impacted, particularly in the Mid Atlantic and the South.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

The good news is that we saw a strong June and the positive momentum continued into July. We are cautiously optimistic that the crews will be able to complete enough road construction projects in the second half such that on a full year basis, Roadtec revenue should be up low single digits. The segment continued to show improved profit and stability as a result of our successful execution of repositioning actions. Segment EBITDA was more than 3x last year's number and EBITDA margin approached 20%, the highest in nearly two years. I'm also pleased to report that we completely consumed the high cost CTO inventory before the end of the quarter and are now recording CTO purchases at market rates, which today are around $550 to $600 per ton.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

In addition to lower raw material costs, repositioning allowed us to right size our footprint, so we are seeing significantly lower costs in our supply chain for logistics, storage and warehousing, for example, which also contributed to the EBITDA improvement. Because we are realizing mix and cost improvements more quickly than originally anticipated, we are increasing our guidance for full year Performance Chemicals EBITDA margin to be in the high single digit to low double digits as we expect second half margins to be similar to first half. In summary, the company's focus on execution excellence is evident in our results through continued improvement and profitability and strong free cash flow, which we are using to accelerate deleveraging. We're pleased with the progress we're making in a very challenging global business environment. And I'll now turn the call back to Dave for an update on guidance and closing comments.

David Li
David Li
President, CEO & Director at Ingevity

Thanks, Mary. Please turn to Slide 10. Given the continued strong performance in Performance Chemicals and sustained 50 plus percent EBITDA margins in Performance Materials, coupled with an improved outlook for North American auto production, we are raising the low end of our full year EBITDA guidance to a range of $390,000,000 to $415,000,000 In addition, with the strong free cash flow we're generating, we're revising our full year free cash flow guidance upward to $230,000,000 to $260,000,000 and we remain highly confident we will achieve our year end net leverage target of below 2.8 times. We are maintaining our sales guidance as we continue to navigate macroeconomic uncertainty and weakness in industrial and consumer demand, as well as potential shifts in interest rates and tariffs during the second half. As I close, let me once again highlight the significant progress the company has made over the last two years as a result of the successful execution of our repositioning strategy.

David Li
David Li
President, CEO & Director at Ingevity

We've posted three straight quarters of year over year improvement in EBITDA and free cash flow, five straight quarters of year over year EBITDA margin improvement and four consecutive quarters of reduced leverage. We believe our results demonstrate that we are building momentum as we transition beyond this repositioning phase. Strategically, we are pleased with the progress of the sale of our Industrial Specialties business and CTO Refinery and expect to provide an update soon. I'm also excited to share that we expect to host an investor update later this year or early next year, where I'll communicate the results of our comprehensive portfolio review, share our long term growth strategy and articulate our vision for Ingevity's future. In closing, our strong results over multiple quarters underscores the strength of our execution and the momentum we are building across the company.

David Li
David Li
President, CEO & Director at Ingevity

With more stable and profitable businesses, a strengthened financial profile and a clear strategic direction, we believe Ingevity has passed an inflection point and is well positioned for sustained growth and long term value creation. With that, I'll turn it over for questions.

Operator

Our first question comes from John Tanwanteng from CJS Securities. John, please go ahead. Your line is open.

Jonathan Tanwanteng
Managing Director at CJS Securities

Hi. Good morning. Thank you for taking my questions, and congrats on a nice earnings quarter and the higher outlook for the year. Maybe first of all, could you give us an update on the possibility of the inspectors' stand alone ex payment with CCO prices are relative to a year ago and also relative to, you know, alternative OVOs and and crude alternatives?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Yes. As you know, we don't break out the profitability of that, John. I think where we try to guide people on that is if you look at, keep in mind the seasonality of pavement, which is a Q2, Q3 story and compare that to Q4, Q1, you get an idea of the profitability, relative profitability of in spec. And that's really the best we can do.

David Li
David Li
President, CEO & Director at Ingevity

But John, I'd say, overall, we're pleased to be through the higher cost inventory at CTO. We're pleased with the to be through the repositioning efforts. And as I mentioned, I think we're we feel like we've reached an inflection point for the company.

Jonathan Tanwanteng
Managing Director at CJS Securities

Got it. I was wondering if you could talk about the investments that you mentioned in your prepared remarks, maybe some of the opportunities there, if those are mostly in the carbon segment or others, and to get an update on the already ongoing projects that you have.

David Li
David Li
President, CEO & Director at Ingevity

Yes. Thanks, John. So as you know, we've made investments and have a strong partnership with a company called Nexeon. So part of that investment is continued investment into that partnership, which we're very encouraged about. It will allow us to use our highly engineered activated carbon in the EV segment of the business.

David Li
David Li
President, CEO & Director at Ingevity

Also, we've been participating in other applications for activated carbon, which we call process purification. And I think in the past, although we participated, we haven't been really intentional or haven't developed those channels in an intentional way. And so we're putting some more energy and focus behind that. And I think we'll see some really good results in the future from those investments as well.

Jonathan Tanwanteng
Managing Director at CJS Securities

Okay.

Jonathan Tanwanteng
Managing Director at CJS Securities

And just to sneak one more in, I don't know if Ed is listening, but congratulations on a really exceptional run for the segment. Any thoughts on just what you're looking for in leadership there? And if there's any tweaks you may be doing to the segment?

David Li
David Li
President, CEO & Director at Ingevity

Yes. So as we announced, we after a very long and celebrated career, we had one leader step away from the business, Ed, and really want to acknowledge his contributions to building that business.

David Li
David Li
President, CEO & Director at Ingevity

We have an active search ongoing for his replacement, and we're really pleased with the progress we're making there and excited for that new leader to come aboard. We hope to have that completed search in the next several months, I would say. And then internally, we have a lot of momentum. So we don't want to wait for that new leader to come aboard. We're already reorganizing to focus on, of course, the automotive aspect of the business, but also, as I mentioned, that process purification business, we brought on some new leaders to focus in that area and excited about what they'll bring to that part of the business.

Operator

The next question comes from John McNulty from BMO. John, can you check if you're muted locally?

John McNulty
John McNulty
MD - Chemicals Analyst at BMO Capital Markets

Sorry about that. I was stuck on mute. So on Performance Chemicals, obviously, a really big jump in the margins, maybe bigger than what we were looking for.

John McNulty
John McNulty
MD - Chemicals Analyst at BMO Capital Markets

But a lot of kind of things going on in there. I guess, can you help us to think about what the margin would have been if you didn't have the high cost each go running through the P and L? The assumption would be it would have been even higher and probably in the 20s. But can you help us to maybe think about that?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

So I'll let you I'll give you some insight how I think about that. And then we've got Phil Platt here, our Head of Finance and Accounting here as well. So as I mentioned, when we think about the full year, a lot of noise in the first half as we're working through the high cost CTO. But we did say, I did say, we expect the second half margins to be similar to first half. And again, so that reflects the seasonality of pavement, but also the fact that we will have worked through the high cost CTO and it won't be dragging down the second half of the year.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

But keep in mind that pavement, as I mentioned, had a relatively tough Q2 because of the weather impacts. And I mentioned the strong June and the good momentum in July. So if you think about maybe absent hurricanes and the like, Pavement does a bit better in Q3 than Q2, and we don't have the drag from from the CTO inventory that gets you to kind of that full year look that I gave. Am I what else am I missing, John? Is there something does that help?

David Li
David Li
President, CEO & Director at Ingevity

Yeah. Definitely definitely give us a give us a little little bit of color on it at least.

John McNulty
John McNulty
MD - Chemicals Analyst at BMO Capital Markets

Okay. And then maybe

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Second half second half, John. Yes. Just to be clear, second half won't include the impact of the high cost CPO. And we're saying that the margin we expect the margins to be similar to first half.

John McNulty
John McNulty
MD - Chemicals Analyst at BMO Capital Markets

Fair enough. Okay. That helps. And then on the free cash flow side, so 2Q is normally kind of just about a breakeven type free cash quarter, this time noticeably better than that. I guess, can you help us to think about some of the levers that you're pulling to drive incremental free cash flow as we look forward?

John McNulty
John McNulty
MD - Chemicals Analyst at BMO Capital Markets

Are there some new kind of initiatives or things that you're focused on that to kind of tighten things up or push that push the profitability and the improvement on the cash flow a little bit?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Yes. I think the main drivers in the second quarter were the improved earnings. And we clearly continue to work on our inventory management initiatives. So and with the cost of the inventory also coming down, we see the benefits showing up in working capital.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

So less of the CapEx story, as I mentioned, we are it's pretty typical for us to spend less than the first half of the year on CapEx than we do in the second half. But it's really due primarily to the improved earnings. Yes.

David Li
David Li
President, CEO & Director at Ingevity

And I think, John, just to add on to Mary's comment, we're really pleased with our execution. Obviously, we're seeing benefits from the repositioning strategy clearly through an inflection point there. And I think what we would expect, and we guided to this as well, is really much more predictable cash flows for the business that the underlying strength of our business model, whether it's Performance Materials, which had another 50 plus percent EBITDA quarter, we would expect strong cash flows and predictable cash flows going forward.

Operator

The next question comes from Daniel Rizzo from Jefferies. Daniel, your line is open. Please go ahead.

Daniel Rizzo
Daniel Rizzo
VP - Research Analyst at Jefferies

Hey, good morning. Thanks for taking my questions. You mentioned doing a strategic review just kind of for the whole portfolio. Is this going be like an orderly process that once you're done with what you're thinking about with Industrial Specialties that you'll then move on to the next?

Daniel Rizzo
Daniel Rizzo
VP - Research Analyst at Jefferies

Or is it something that could happen all at once? I mean, is there ongoing conversations with others about different parts of your business that haven't been previously mentioned?

David Li
David Li
President, CEO & Director at Ingevity

Yes. Thanks, Daniel. So what we mentioned is that we're in advanced stages of the sale process of our Industrial Specialties business and CTO Refinery and hopefully have an update too, and we're very encouraged.

David Li
David Li
President, CEO & Director at Ingevity

And at the same time, there's a lot of work going on internally in parallel to look at the entire portfolio. And obviously, we want to be measured here. It's obviously those are some big decisions for the company. And how we're approaching it is just thinking about what are our core competencies, where are we the best owner and then transposing kind of financial profile of the different businesses, where can we really add value. And that work is ongoing now.

David Li
David Li
President, CEO & Director at Ingevity

We would expect that to be completed. And we mentioned that we'd be providing an investor update hopefully by the end of the year, might be early next year, but that work is already ongoing. It also includes a look at where we are where we have opportunities to grow. So there may be opportunities. I mentioned one, process purification within Performance Materials, where perhaps we've under resourced in the past and we see opportunities for growth.

David Li
David Li
President, CEO & Director at Ingevity

So we'll be able to talk more about that in the second half or later in the year, but that process is ongoing as we speak.

Daniel Rizzo
Daniel Rizzo
VP - Research Analyst at Jefferies

Thanks for that. And then you mentioned that CECL prices now as you purchase the money open market, I think it's $5.50 to 600 a ton. I was just wondering what that is as comparing to what your high cost one was from the beginning of the year and late last year. And if and how we should think about it going forward?

Daniel Rizzo
Daniel Rizzo
VP - Research Analyst at Jefferies

Is the market long CTO now or just given what you've done? Or you know, how we should just think about these costs versus versus your other inputs in the back half of the year?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Yeah. The flat 50 to 600, again, we use that ARGUS data versus what we were paying before. I think we, at one time, had talked about levels even in the it was buyback current market conditions at a time when the CTO market prices were in a similar area. So the reality is we were we with the downsizing of our footprint, our CTO purchase requirements, volume requirements also came down. So the combination of requiring less CTO as well as the lower prices is really what you're seeing in those improved results in the first half of this year.

Daniel Rizzo
Daniel Rizzo
VP - Research Analyst at Jefferies

And going forward?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

And going forward, yes. I mean volume of purchases would be similar to what we saw in Q2. And the price, again, we're comfortable that we have enough CTO to run our operations and certainly are less dependent on the vagaries of the CTO market and how pricing is moving than we have ever been in the past.

Operator

The next question is from Mike Sison from Wells Fargo.

Michael Sison
Michael Sison
Managing Director at Wells Fargo Securities

Nice quarter and outlook. Guess first question in terms of Performance Materials, you got pricing again. It seems like the ability to get pricing has been very good over the years. Can you sort of talk about why in the year with down volumes you've been able to get pricing and how that looks for the second half of the year?

David Li
David Li
President, CEO & Director at Ingevity

Right. So thanks for the question. I think just first touching base on the business itself, we see pretty resilient. Obviously, we're very North American centric from a business perspective. We sell globally, but the North American market is very important to us, and that's proven to be pretty resilient, whether it's North American auto production or so far the consumers buying behavior.

David Li
David Li
President, CEO & Director at Ingevity

With respect to pricing, I think it's just reflective of the value that we're providing to customers. We're providing a highly engineered activated carbon solution. Customers are delighted with the products and the technology. We continue to work closely with those key customers globally. And so that pricing and that value that we're getting back is just reflective, I think, of what we're providing to those customers.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

And as you know, Mike, we've always been able to get price in price increases in that business. That has been really unique, we believe, in as an auto supplier in that chain, that we were able to get those price increases every year. And I think it is a clear sign of that business' resilience that in the face of kind of the tariff uncertainty this year, we've been able to continue just kind of business as usual on the pricing front.

Michael Sison
Michael Sison
Managing Director at Wells Fargo Securities

Got it. And then shifting gears to Advanced Polymer Technologies. David, this is this business seems to have underperformed quite a bit over the years. Just curious to your thoughts on the business itself. What needs to happen for this to be considered a core business longer term?

Michael Sison
Michael Sison
Managing Director at Wells Fargo Securities

And what's sort of your assessment of this segment, I

David Li
David Li
President, CEO & Director at Ingevity

guess, is the question. Yes. Thanks for the question. First, as we mentioned in the last call, we have new leadership in place. And that team, I think, is doing a really great job taking a look at the entire whether it's the commercial approach or our approach towards innovation.

David Li
David Li
President, CEO & Director at Ingevity

And so we're encouraged, and I think we'll see benefits from those that team and that leadership in the near term. I think as I mentioned in the midterm, from a portfolio perspective, we're looking at the entire portfolio and seeing really where we can add value, where we can be the best owner. APT will be part of that review. And as I mentioned, we'll have more to say on it towards the end of the year. But also, as Mary mentioned, we just got through a pretty major CapEx investment.

David Li
David Li
President, CEO & Director at Ingevity

We're pleased with that, how it's come online. And so I think the team is in place. The leadership is in place. So I think we're set up well in the near term. In the mid to longer term, we're looking at the portfolio and more to come.

Michael Sison
Michael Sison
Managing Director at Wells Fargo Securities

Great. And then just one quick last one. Your free cash flow looks pretty good. I think you raised that and the goal is to lower debt, get your leverage ratio down. So beyond this year, what do you think is the right way to deploy cash going forward if the leverage looks good beyond this year?

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Sure. And where you finished getting the debt to our target area, that two to 2.5 times is clearly our priority. But beyond that, again, investing organically. As I mentioned, we're continuing to do some of that. We continue to see pathways for growth organically and want to give that the priority that it's due.

Mary Hall
Mary Hall
Executive VP & CFO at Ingevity

Share repurchases, in our past, the leverage got elevated, we were a regular participator in share repurchases. And I think that is something that clearly is on our radar as well in terms of returning cash to shareholders. M and A, in terms of our capital allocation priorities, Again, not a priority in the near term, clearly, but something that is always on the list to the extent that once we are stable, generating a lot of free cash flow, the other capital allocation priorities are hitting on all cylinders. We will have the flexibility to look at M and A opportunities when they arrive.

Executives
    • John Nypaver
      John Nypaver
      Vice President of Treasurer & Investor Relations
    • David Li
      David Li
      President, CEO & Director
    • Mary Hall
      Mary Hall
      Executive VP & CFO
Analysts
Powered by Quartr